Avellino
Avellino is a genomics company focused on transforming healthcare through data-driven insights, powered by artificial intelligence and machine learning. The company's expertise encompasses eye care, oncology, genomic analytics, pathogenomics, and infectious diseases like COVID/RSV testing. Avellino offers products such as Av CoV2 and Av CoV2 Respiratory, and a Patient Hub. Their approach involves predicting disease before clinical management, utilizing multi-datapoint polygenic risk scores and novel treatment methods. Avellino aims to make genetics approachable and understandable, with a focus on health equity and inclusivity in their studies to maximize global healthcare impact. They have completed over one million genetic eye tests since 2008 and tested over four million patients for COVID and RSV.
Avellino
Avellino is a genomics company focused on transforming healthcare through data-driven insights, powered by artificial intelligence and machine learning. The company's expertise encompasses eye care, oncology, genomic analytics, pathogenomics, and infectious diseases like COVID/RSV testing. Avellino offers products such as Av CoV2 and Av CoV2 Respiratory, and a Patient Hub. Their approach involves predicting disease before clinical management, utilizing multi-datapoint polygenic risk scores and novel treatment methods. Avellino aims to make genetics approachable and understandable, with a focus on health equity and inclusivity in their studies to maximize global healthcare impact. They have completed over one million genetic eye tests since 2008 and tested over four million patients for COVID and RSV.